Psych CASC / OSCE · General adult psychiatry — somatic symptom and related
Explain illness anxiety, CBT and collaborative care — CASC communication station
MRCPsych/FRANZCP-style communication station: explain IAD, CBT health anxiety, SSRI, anti-collusion with testing, family accommodation, safety-netting.
On this page & tools
Target exams
Station brief
Format. Communication station, approximately 7–10 minutes active time after reading. You are the psychiatry registrar in the outpatient clinic. [2]
Candidate instructions. Explain illness anxiety disorder in plain language, outline specialised CBT with exposure and response prevention elements, discuss a possible SSRI (e.g. fluoxetine or sertraline) with delayed full benefit, explain why further imaging without new clinical change is not the treatment, address partner reassurance, and check understanding. The examiner plays the patient. [1][4]
Candidate scenario
Your patient meets criteria for IAD after normal imaging. You plan referral for CBT for health anxiety and discussion of an SSRI such as fluoxetine 20 mg orally daily (or sertraline) with early review. She fears CBT means “ignoring real cancer” and believes one more MRI will end the problem. Her partner currently checks her breasts each evening to “reassure” her. [1][3]
Marking domains
- Empathy, structure and agenda-setting
- Accurate plain-language model (sensations/news → catastrophic fear → checking/internet/reassurance → short relief)
- Clear CBT explanation (hierarchy, response prevention, homework)
- Medication discussion: start dose concept, delayed full benefit, side-effects, monitoring
- Explicit collaborative plan: no non-indicated MRI tonight; criteria for re-presentation
- Family accommodation advice without blame
- Safety-net for worsening mood/suicidality
- Checks understanding / teach-back [2][5]
Reveal assessor key
Open and agenda-set. Name time; ask main fears (missing cancer; losing partner support; medication changing personality). [2]
Explain IAD. “Illness anxiety disorder is a recognised condition where the mind’s threat system locks onto fear of serious disease even when symptoms are mild and careful tests are normal. Checking and online searching briefly calm the fear but keep the cycle going. It is not faking and not a character flaw.” [4]
Explain CBT. Therapy helps you gradually face body sensations and uncertainty while reducing checking, internet searching and reassurance, so the brain learns anxiety falls without those rituals. We use a step-by-step ladder. Evidence supports specialised CBT, including programmes adapted for medical patients. [1][2]
Medication. An SSRI such as fluoxetine can reduce the intensity of health anxiety and low mood; we often start around 20 mg daily by mouth and review early; full benefit may take several weeks; report side-effects. It is not an intoxicating “personality eraser.” Combine with CBT when possible. [3]
Investigations. Further scans without new warning signs often fuel the anxiety cycle rather than cure it. We will stay open to re-checking if new red-flag changes appear, with one coordinating doctor. [2]
Partner role. Endless evening checks act like a short-acting sedative for fear — we will coach planned support without ritual checking. [4]
Safety-net. If mood drops or you have thoughts of harming yourself, contact crisis services / ED / us same day — health anxiety is associated with serious distress and elevated suicide risk in research cohorts. Teach-back. [5]
Common station failures
Saying “nothing is wrong” without a both–and model; agreeing to unlimited imaging for peace of mind; omitting suicide safety-netting; explaining medication without linking to CBT or monitoring; blaming the partner rather than coaching accommodation reduction.[1][2][5]
References
- [1]Barsky AJ, Ahern DK Cognitive behavior therapy for hypochondriasis: a randomized controlled trial JAMA, 2004.PMID 15039413
- [2]Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial Lancet, 2014.PMID 24139977
- [3]Fallon BA, Ahern DK, Pavlicova M, et al. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis Am J Psychiatry, 2017.PMID 28659038
- [4]Warwick HM, Salkovskis PM Hypochondriasis Behav Res Ther, 1990.PMID 2183757
- [5]Mataix-Cols D, Isomura K, Sidorchuk A, et al. All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis JAMA Psychiatry, 2024.PMID 38091000